603520 司太立
已收盘 12-12 15:00:00
资讯
新帖
简况
司太立最新公告：全资子公司上海司太立获得钆喷酸葡胺注射液药品注册证书
证券之星 · 11-25
司太立最新公告：全资子公司上海司太立获得钆喷酸葡胺注射液药品注册证书
每周股票复盘：司太立（603520）临时股东会通过多项治理议案
证券之星 · 11-23
每周股票复盘：司太立（603520）临时股东会通过多项治理议案
司太立（603520）披露取消监事会及调整董事会人数等议案获通过，11月20日股价下跌2.44%
证券之星 · 11-20
司太立（603520）披露取消监事会及调整董事会人数等议案获通过，11月20日股价下跌2.44%
11月13日司太立涨5.82%，华商品质价值混合A基金重仓该股
证券之星 · 11-13
11月13日司太立涨5.82%，华商品质价值混合A基金重仓该股
每周股票复盘：司太立（603520）高管姚朝阳因个人原因离职
证券之星 · 11-09
每周股票复盘：司太立（603520）高管姚朝阳因个人原因离职
11月7日司太立涨5.33%，华商品质价值混合A基金重仓该股
证券之星 · 11-07
11月7日司太立涨5.33%，华商品质价值混合A基金重仓该股
司太立（603520）披露高级管理人员离职公告，11月03日股价下跌2.6%
证券之星 · 11-03
司太立（603520）披露高级管理人员离职公告，11月03日股价下跌2.6%
司太立（603520）披露拟取消监事会并修订公司章程，10月31日股价上涨2.48%
证券之星 · 10-31
司太立（603520）披露拟取消监事会并修订公司章程，10月31日股价上涨2.48%
图解司太立三季报：第三季度单季净利润同比增长97.77%
证券之星 · 10-30
图解司太立三季报：第三季度单季净利润同比增长97.77%
司太立(603520)9月30日股东户数3.26万户，较上期减少2.66%
证券之星 · 10-30
司太立(603520)9月30日股东户数3.26万户，较上期减少2.66%
每周股票复盘：司太立（603520）每股派现0.05元（含税）
证券之星 · 09-07
每周股票复盘：司太立（603520）每股派现0.05元（含税）
每周股票复盘：司太立（603520）中报净利增27.24%，拟每10股派0.5元
证券之星 · 08-31
每周股票复盘：司太立（603520）中报净利增27.24%，拟每10股派0.5元
司太立最新公告：拟6644万元转让研诺医药9.87%股权
证券之星 · 08-28
司太立最新公告：拟6644万元转让研诺医药9.87%股权
司太立：2025年上半年净利润2913.55万元，同比增长27.24%
金融界 · 08-28
司太立：2025年上半年净利润2913.55万元，同比增长27.24%
异动快报：司太立（603520）8月19日9点50分触及涨停板
证券之星 · 08-19
异动快报：司太立（603520）8月19日9点50分触及涨停板
司太立：35G(I)规格获批 API+制剂一体化持续推进
平安证券股份有... · 08-12
司太立：35G(I)规格获批 API+制剂一体化持续推进
研报掘金丨平安证券：司太立业绩改善确定性较强，维持“推荐”评级
格隆汇 · 08-12
研报掘金丨平安证券：司太立业绩改善确定性较强，维持“推荐”评级
司太立涨5.25% 产业壁垒支撑估值修复预期
智选洞察 · 07-31
司太立涨5.25% 产业壁垒支撑估值修复预期
司太立涨5.09%创近7个月新高 产能释放与市占率提升支撑股价
智选洞察 · 07-28
司太立涨5.09%创近7个月新高 产能释放与市占率提升支撑股价
每周股票复盘：司太立（603520）大宗交易机构净卖出314.46万元
证券之星 · 07-20
每周股票复盘：司太立（603520）大宗交易机构净卖出314.46万元
加载更多
公司概况
公司名称：
浙江司太立制药股份有限公司
所属行业：
医药制造业
上市日期：
2016-03-09
主营业务：
浙江司太立制药股份有限公司的主营业务是原料药（碘海醇、碘克沙醇、碘帕醇、碘佛醇、盐酸左氧氟沙星、左氧氟沙星、甲磺酸帕珠沙星）、医药中间体、制剂的研发、生产和销售。公司的主要产品是碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、碘美普尔注射液、碘佛醇注射液、钆贝葡胺注射液、造影剂类原料药及中间体、喹诺酮类原料药及中间体、CMO/CDMO类原料药及中间体。
发行价格：
12.15
{"stockData":{"symbol":"603520","market":"SH","secType":"STK","nameCN":"司太立","latestPrice":9.53,"timestamp":1765522800000,"preClose":9.52,"halted":0,"volume":5567904,"delay":0,"changeRate":0.0011,"floatShares":438000000,"shares":438000000,"eps":-0.0668,"marketStatus":"已收盘","change":0.01,"latestTime":"12-12 15:00:00","open":9.57,"high":9.6,"low":9.48,"amount":53128300,"amplitude":0.0126,"askPrice":9.54,"askSize":249,"bidPrice":9.53,"bidSize":278,"shortable":0,"etf":0,"ttmEps":-0.0668,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":9.52,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":10.47,"lowLimit":8.57,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":438409881,"isCdr":false,"pbRate":1.61,"roa":"--","roe":"1.1%","epsLYR":-0.12,"committee":0.228225,"marketValue":4178000000,"turnoverRate":0.0127,"status":0,"floatMarketCap":4178000000},"requestUrl":"/m/hq/s/603520","defaultTab":"news","newsList":[{"id":"2586456447","title":"司太立最新公告：全资子公司上海司太立获得钆喷酸葡胺注射液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2586456447","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586456447?lang=zh_cn&edition=full","pubTime":"2025-11-25 15:41","pubTimestamp":1764056516,"startTime":"0","endTime":"0","summary":"司太立(603520.SH)公告称，公司全资子公司上海司太立近日收到国家药监局核准签发的钆喷酸葡胺注射液《药品注册证书》。该药品主要用于中枢神经（脑及脊髓）、腹、胸、盆腔、四肢等人体脏器和组织的磁共振成像。这是公司继钆贝葡胺注射液之后第二个获得药品注册证书的磁共振造影剂产品，进一步丰富了公司制剂产品管线。药品销售受医药行业政策、招投标、市场环境变化等诸多因素影响而存在不确定性，因此本次获得药品注册证书对公司业绩的影响存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500017551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2585038611","title":"每周股票复盘：司太立（603520）临时股东会通过多项治理议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2585038611","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585038611?lang=zh_cn&edition=full","pubTime":"2025-11-23 02:04","pubTimestamp":1763834656,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，司太立报收于9.94元，较上周的11.87元下跌16.26%。本周关注点公司公告汇总：司太立2025年第一次临时股东会审议通过续聘审计机构、取消监事会等多项议案。司太立2025年第一次临时股东会法律意见书北京金诚同达律师事务所就浙江司太立制药股份有限公司2025年第一次临时股东会的召集、召开程序，出席会议人员资格、召集人资格，表决程序及表决结果等事项出具法律意见书。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300000403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2584303341","title":"司太立（603520）披露取消监事会及调整董事会人数等议案获通过，11月20日股价下跌2.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584303341","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584303341?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:15","pubTimestamp":1763648123,"startTime":"0","endTime":"0","summary":"截至2025年11月20日收盘，司太立报收于10.4元，较前一交易日下跌2.44%，最新总市值为45.59亿元。根据近日发布的公告，浙江司太立制药股份有限公司于2025年11月20日召开2025年第一次临时股东会，会议审议通过了续聘2025年度审计机构、对全资子公司增资、取消监事会、调整董事会人数、修订公司章程部分条款以及多项治理制度议案，包括股东会议事规则、董事会议事规则、独立董事制度等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000038113.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2583542975","title":"11月13日司太立涨5.82%，华商品质价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2583542975","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583542975?lang=zh_cn&edition=full","pubTime":"2025-11-13 16:26","pubTimestamp":1763022402,"startTime":"0","endTime":"0","summary":"证券之星消息，11月13日司太立涨5.82%，收盘报12.36元，换手率11.42%，成交量50.06万手，成交额6.15亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为华商基金的华商品质价值混合A。华商品质价值混合A目前规模为8.63亿元，最新净值1.7362，较上一交易日下跌0.5%，近一年上涨43.89%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300027546.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2582869310","title":"每周股票复盘：司太立（603520）高管姚朝阳因个人原因离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2582869310","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582869310?lang=zh_cn&edition=full","pubTime":"2025-11-09 02:30","pubTimestamp":1762626635,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，司太立报收于11.06元，较上周的11.15元下跌0.81%。本周，司太立11月7日盘中最高价报11.49元。公司公告汇总司太立关于高级管理人员离职的公告：姚朝阳因个人原因辞去公司副总经理职务，离任时间为2025年10月31日，原定任期至2026年5月9日。其辞职报告自送达公司董事会之日起生效。姚朝阳离任后不再在上市公司及其控股子公司任职，不存在未履行完毕的公开承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900000490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2581072533","title":"11月7日司太立涨5.33%，华商品质价值混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2581072533","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581072533?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:16","pubTimestamp":1762503392,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日司太立涨5.33%，收盘报11.06元，换手率7.8%，成交量34.2万手，成交额3.79亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共7家，其中持有数量最多的公募基金为华商基金的华商品质价值混合A。华商品质价值混合A目前规模为8.63亿元，最新净值1.7491，较上一交易日上涨1.07%，近一年上涨47.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700024816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2580114442","title":"司太立（603520）披露高级管理人员离职公告，11月03日股价下跌2.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580114442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580114442?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:23","pubTimestamp":1762179838,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，司太立报收于10.86元，较前一交易日下跌2.6%，最新总市值为47.61亿元。该股当日开盘11.15元，最高11.15元，最低10.81元，成交额达1.38亿元，换手率为2.88%。近日，司太立发布关于高级管理人员离任的公告。公告显示，姚朝阳因个人原因辞去公司副总经理职务，离任时间为2025年10月31日，原定任期至2026年5月9日。其辞职报告自送达公司董事会之日起生效。姚朝阳离任后不再在上市公司及其控股子公司任职，不存在未履行完毕的公开承诺。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2579445460","title":"司太立（603520）披露拟取消监事会并修订公司章程，10月31日股价上涨2.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579445460","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579445460?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:53","pubTimestamp":1761904394,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，司太立报收于11.15元，较前一交易日上涨2.48%，最新总市值为48.88亿元。根据公司于近日发布的公告，浙江司太立制药股份有限公司将于2025年11月20日召开2025年第一次临时股东大会，会议将审议多项议案。此外，会议还将审议续聘天健会计师事务所为2025年度审计机构、对全资子公司上海司太立增资6,000万元以及制定或修订多项公司治理制度等议案。上述议案已获董事会审议通过，相关资料已于2025年10月31日披露于上海证券交易所网站。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100038312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2579143717","title":"图解司太立三季报：第三季度单季净利润同比增长97.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579143717","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579143717?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:42","pubTimestamp":1761824579,"startTime":"0","endTime":"0","summary":"证券之星消息，司太立2025年三季报显示，前三季度公司主营收入18.45亿元，同比上升2.24%；归母净利润2882.48万元，同比上升221.14%；扣非净利润2737.78万元，同比上升531.19%；其中2025年第三季度，公司单季度主营收入4.47亿元，同比下降5.66%；单季度归母净利润-31.06万元，同比上升97.77%；单季度扣非净利润9.83万元，同比上升100.62%；负债率55.44%，投资收益-488.75万元，财务费用4613.13万元，毛利率21.83%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000040273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520"],"gpt_icon":0},{"id":"2579118839","title":"司太立(603520)9月30日股东户数3.26万户，较上期减少2.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579118839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579118839?lang=zh_cn&edition=full","pubTime":"2025-10-30 17:22","pubTimestamp":1761816147,"startTime":"0","endTime":"0","summary":"证券之星消息，近日司太立披露，截至2025年9月30日公司股东户数为3.26万户，较7月6日减少891.0户，减幅为2.66%。在化学制药行业个股中，司太立股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.43万户。从股价来看，2025年7月6日至2025年9月30日，司太立区间涨幅为9.14%，在此期间股东户数减少891.0户，减幅为2.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000032712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2565654684","title":"每周股票复盘：司太立（603520）每股派现0.05元（含税）","url":"https://stock-news.laohu8.com/highlight/detail?id=2565654684","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565654684?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:12","pubTimestamp":1757200338,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，司太立报收于11.69元，较上周的11.64元上涨0.43%。本周，司太立9月2日盘中最高价报12.24元。本周关注点公司公告汇总：司太立每股派发现金红利0.05元（含税），股权登记日为2025年9月11日。本次利润分配以公司总股本438,409,881股为基数，每股派发现金红利0.05元（含税），合计派发现金红利21,920,494.05元。A股股东持股期限不同，税负有所差异，持股1个月以内税负20%，1个月至1年税负10%，超过1年免税。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2563183834","title":"每周股票复盘：司太立（603520）中报净利增27.24%，拟每10股派0.5元","url":"https://stock-news.laohu8.com/highlight/detail?id=2563183834","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563183834?lang=zh_cn&edition=full","pubTime":"2025-08-31 13:57","pubTimestamp":1756619826,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，司太立报收于11.64元，较上周的11.54元上涨0.87%。股本股东变化股东户数变动截至2025年7月6日，司太立股东户数为3.35万户，较3月31日减少4396户，减幅11.59%。司太立2025年半年度报告摘要截至报告期末，股东总数为33,731户。司太立关于2025年中期利润分配预案的公告公司拟以实施权益分派股权登记日总股本为基数，向全体股东每10股派发现金红利0.5元（含税）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100004769.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2562084884","title":"司太立最新公告：拟6644万元转让研诺医药9.87%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2562084884","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562084884?lang=zh_cn&edition=full","pubTime":"2025-08-28 17:06","pubTimestamp":1756371998,"startTime":"0","endTime":"0","summary":"司太立(603520.SH)公告称，公司拟与复星万邦签署协议，以6644.16万元对价转让所持研诺医药740,001元注册资本对应的股权，约占研诺医药注册资本总额的9.87%。预计交易完成后，公司将不再持有研诺医药股权。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082800031697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","09939","159938","BK1515","603520","BK1574"],"gpt_icon":0},{"id":"2562086517","title":"司太立：2025年上半年净利润2913.55万元，同比增长27.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562086517","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562086517?lang=zh_cn&edition=full","pubTime":"2025-08-28 16:08","pubTimestamp":1756368484,"startTime":"0","endTime":"0","summary":"司太立公告，2025年上半年营业收入13.98亿元，同比增长5.06%。净利润2913.55万元，同比增长27.24%。公司拟以实施权益分派股份登记日的总股本为基数，向全体股东每10股派发现金红利0.5元（含税），合计拟派发现金红利2192.05万元（含税）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/08/28160852774041.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["603520"],"gpt_icon":0},{"id":"2560015802","title":"异动快报：司太立（603520）8月19日9点50分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2560015802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560015802?lang=zh_cn&edition=full","pubTime":"2025-08-19 09:55","pubTimestamp":1755568527,"startTime":"0","endTime":"0","summary":"证券之星8月19日盘中消息，9点50分司太立触及涨停板。目前价格12.16，上涨10.05%。其所属行业化学制药目前上涨。领涨股为北陆药业。该股为医药，化学原料药概念热股，当日医药概念上涨2.0%，化学原料药概念上涨1.7%。8月18日的资金流向数据方面，主力资金净流出576.37万元，占总成交额4.77%，游资资金净流入396.6万元，占总成交额3.29%，散户资金净流入179.77万元，占总成交额1.49%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900009855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2558762611","title":"司太立：35G(I)规格获批 API+制剂一体化持续推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2558762611","media":"平安证券股份有...","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558762611?lang=zh_cn&edition=full","pubTime":"2025-08-12 15:05","pubTimestamp":1754982355,"startTime":"0","endTime":"0","summary":"事项：7月31日，司太立碘佛醇100ml:35g规格获国家药监局批准。平安观点：碘佛醇是碘造影剂第一大品种，100ml:35g规格占比约80%。司太立碘佛醇100ml:32g规格于2023年10月获药监局批准，2024年销售规模较小。我们认为本次主流规格获批后，公司碘佛醇销售规模有望加速放量。原料药加制剂一体化优势逐步体现。API和制剂有望迎来同步放量，静待碘价回落，维持“推荐”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081215061294de501b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081215061294de501b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2558619219","title":"研报掘金丨平安证券：司太立业绩改善确定性较强，维持“推荐”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2558619219","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558619219?lang=zh_cn&edition=full","pubTime":"2025-08-12 14:49","pubTimestamp":1754981372,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["603520","BK0239","161027"],"gpt_icon":0},{"id":"2555072241","title":"司太立涨5.25% 产业壁垒支撑估值修复预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2555072241","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555072241?lang=zh_cn&edition=full","pubTime":"2025-07-31 11:13","pubTimestamp":1753931618,"startTime":"0","endTime":"0","summary":"司太立股价大幅上涨，最新价11.63元/股，涨幅达5.25%。主力调仓与成本压力共振司太立近期净流出与主力资金高频调仓密切相关。原材料碘成本同比上涨18%，短期压制企业毛利率修复进程，触发部分资金阶段性离场。产业壁垒与成长动能蓄力司太立长期竞争力仍具韧性，造影剂领域龙头地位持续夯实。尽管2024年净利润亏损4909.9万元，但海外收入占比升至33.52%，若成本优化与产能爬坡形成共振，1.96倍市净率的估值修复值得关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731111349a6cab4e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731111349a6cab4e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","603520"],"gpt_icon":0},{"id":"2554174221","title":"司太立涨5.09%创近7个月新高 产能释放与市占率提升支撑股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2554174221","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554174221?lang=zh_cn&edition=full","pubTime":"2025-07-28 10:06","pubTimestamp":1753668389,"startTime":"0","endTime":"0","summary":"司太立股价今日表现强势，截至10点05分，最新价报10.94元，上涨5.09%，创近7个月新高。资金博弈与成本压力共振引发波动近日司太立股价波动加剧，主力资金高频调仓成为主要推手。截至7月25日，主力资金连续两日净流出2343.4万元，市场短期博弈情绪升温。产能释放与市占率提升构筑基本面支撑司太立长期成长逻辑依然清晰。造影剂集采续约价格降幅收窄至5%-8%，2024年报显示其国内市占率提升至35%，行业龙头地位持续夯实。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728100632a466aab9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728100632a466aab9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603520","BK0239"],"gpt_icon":0},{"id":"2552818410","title":"每周股票复盘：司太立（603520）大宗交易机构净卖出314.46万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552818410","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552818410?lang=zh_cn&edition=full","pubTime":"2025-07-20 06:05","pubTimestamp":1752962720,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘，司太立（603520）报收于10.34元，较上周的10.13元上涨2.07%。本周，司太立7月17日盘中最高价报10.37元。7月14日盘中最低价报10.03元。司太立当前最新总市值45.33亿元，在化学制药板块市值排名110/150，在两市A股市值排名3377/5149。本周关注点交易信息汇总: 7月16日司太立现1笔大宗交易，机构净卖出314.46万元交易信息汇总7月16日司太立现1笔大宗交易，机构净卖出314.46万元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000001470.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765555047666,"stockEarnings":[{"period":"1week","weight":-0.0226},{"period":"1month","weight":-0.1807},{"period":"3month","weight":-0.2013},{"period":"6month","weight":-0.043},{"period":"1year","weight":-0.0667},{"period":"ytd","weight":0.1106}],"compareEarnings":[{"period":"1week","weight":-0.0006},{"period":"1month","weight":-0.0323},{"period":"3month","weight":0.0007},{"period":"6month","weight":0.147},{"period":"1year","weight":0.1284},{"period":"ytd","weight":0.1556}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江司太立制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"32629人(较上一季度减少2.66%)","perCapita":"13436股","listingDate":"2016-03-09","address":"浙江省台州市仙居县现代工业集聚区司太立大道1号","registeredCapital":"43840万元","survey":" 浙江司太立制药股份有限公司的主营业务是原料药（碘海醇、碘克沙醇、碘帕醇、碘佛醇、盐酸左氧氟沙星、左氧氟沙星、甲磺酸帕珠沙星）、医药中间体、制剂的研发、生产和销售。公司的主要产品是碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、碘美普尔注射液、碘佛醇注射液、钆贝葡胺注射液、造影剂类原料药及中间体、喹诺酮类原料药及中间体、CMO/CDMO类原料药及中间体。","listedPrice":12.15},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"司太立(603520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供司太立(603520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"司太立,603520,司太立股票,司太立股票老虎,司太立股票老虎国际,司太立行情,司太立股票行情,司太立股价,司太立股市,司太立股票价格,司太立股票交易,司太立股票购买,司太立股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"司太立(603520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供司太立(603520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}